Economic implications of long-acting opioid switching

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Alpha-2 Adrenoceptor Ligands and Opioid Drugs: Pharmacological Interactions of Therapeutic Interest

By  

Current Neuropharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 343-352

Bentham Science Publishers

Access to resources Recommend Favorite

Bayesian Statistics in Medical Devices: Innovation Sparked by the FDA

By Campbell Gregory  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 5, 2011-09 ,pp. : 871-887

Taylor & Francis Ltd

Access to resources Recommend Favorite

Secondary tumours with BRAF-inhibitors sparked by mutations

By  

Reactions Weekly, Vol. 1, Iss. 1389, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Sorafenib induces considerable muscular atrophy

By  

Reactions Weekly, Vol. 1, Iss. 1289, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite